Alberto is the Head of the Cell and Gene Technologies Business Unit at Lonza Pharma & Biotech, the leading global CDMO with a prominent presence in new modalities.
— Sachs Associates (@SachsAssociates) August 25, 2020
e-Meet Alberto at #Sachs_BEF
More info @ https://t.co/XI3zEYGyl2 pic.twitter.com/4Nm8vp3qp5